Krystal Biotech
Background & Management. Financing Activity. HSV-1 vectors. Dystrophic epidermolysis bullosa (DEB). Vyjuvek (B-VEC). Clinical data summary. DEB market. Management of DEB. Prevalence & Incidence of DEB. Forecasting Vyjuvek sales. Vyjuvek competition. Jeune Aesthetics. Pipeline (KB105, KB407, KB408, KB707, KB104). Valuation.
